23 November 2018
Two teams from the CHUV Department of Psychiatry are publishing results indicating the important role of antioxidants in preventing the harmful consequences of childhood trauma in psychosis. The team of Prof. Kim Do, Director of the Centre for Psychiatric Neurosciences Read more…
5 November 2018
The Centre for Psychiatric Neuroscience and the CHUV-Department of General Psychiatry have just published the results of a study suggesting the protective effects of antioxidant treatment on the brains of young adults suffering from psychosis. For several years, the Centre Read more…
4 November 2018
Two units of the Department of Psychiatry, in partnership with the Harvard Medical School, have tried innovative treatment in patients who have recently developed psychosis. Their results were published in the journal Schizophrenia Bulletin. The Schizophrenia Research Unit of the Read more…
1 August 2018
Kim Do receiving the 2018 SIRS Outstanding Basic Science Award, and Professor René Kahn. Kim Do has devoted most of her career to understanding the origins, effects and potential opportunities linked to an observation she made in patients suffering from Read more…
NAC improves fornix integrity in parallel to the increase of brain glutathione and cognition improvement. 6-month longitudinal gFA changes : NAC vs Placebo. Coronal, sagittal and axial views show voxel-wise analysis results indicating location (body of the fornix) of time Read more…
12 April 2018
Prof. Kim Do Cuénod, Head of the Psychiatric Neuroscience Center (CNP-CHUV), has been awarded with the SIRS Outstanding Basic Science Award 2017-2018 in recognition of her outstanding contribution to schizophrenia research. A pioneer in translational psychiatry research Kim Do Cuénod Read more…
1 February 2018
Neurobiologist, Kim Do Cuénod has specialized in the etiology and pathophysiology of schizophrenia. She is Head of the Schizophrenia Research Unit and Head of the Center for Psychiatric Neuroscience at the CHUV Department of Psychiatry, Prilly. She was nominated UNIL Professor on Read more…
27 November 2017
A joint team between the Lausanne CHUV and Harvard American University paves the way for a new neuroprotective treatment for schizophrenia. Three questions to Kim Do, head of the Center for Psychiatric Neuroscience at the CHUV-Prilly: You have successfully tested Read more…
18 November 2017
The Centre of Psychiatric Neurosciences (CNP) schizophrenia research Unit (Prof. Kim Do Cuénod) and the CHUV General Psychiatry Department (Prof. Philippe Conus), in partnership with the Harvard Medical School of Boston (Prof. Larry Seidman), have conducted a clinical trial with Read more…
